View U.S. Patent No. 10082506 in PDF Format
I1111111111111111 1111111111 11111 1111111111 11111 11111 11111 lll111111111111111 USO 10082506B2 c12) United States Patent (IO) Patent No.: US 10,082,506 B2 Kiessling et al. (45) Date of Patent: Sep.25,2018 (54) MICROBIAL GLYCANS AS A TARGET OF OTHER PUBLICATIONS HUMAN INTELECTIN Tsuji et al., The Journal of Biological Chemistry, 200 l; 276(26): (71) Applicant: Wisconsin Alumni Research 23456-23463. * Foundation, Madison, WI (US) Wesener et al., Nature Structural and Molecular Biology, 2015; 22(8): 603-610.* (72) Inventors: Laura L. Kiessling, Madison, WI (US); Blixt et al., "Printed covalent glycan array for ligand profiling of Darryl A. Wesener, Madison, WI (US); diverse glycan binding proteins," Proc Natl Acad Sci USA, Kittikhun Wangkanont, Bangkok (TH) 101(49):17033-17038, 2004. Datta et al., "Identification of novel genes in intestinal tissue that are (73) Assignee: Wisconsin Alumni Research regulated after infection with an intestinal nematode parasite," Foundation, Madison, WI (US) Infect. Immun., 73(7):4025-4033, 2005. French et al., "Up-regulation of intelectin in sheep after infection ( *) Notice: Subject to any disclaimer, the term ofthis with Teladorsagia circumcincta," Int. J Parasitol., 38(3-4):467- patent is extended or adjusted under 35 475, 2008. U.S.C. 154(b) by O days. Kincaid et al., "Virtual screening for UDP-galactopyranose mutase ligands identifies a new class of antimycobacterial agents," ACS (21) Appl. No.: 14/933,891 Chem. Biol., 10:2209-2218, 2015. Nassau et al., "Galactofuranose biosynthesis in Escherichia coli (22) Filed: Nov. 5, 2015 K-12: identification and cloning ofUDP-galactopyranose mutase ," J Bacterial, 178(4):1047-1052, 1996.
[Show full text]